Journal of International Psychiatry

[Abstract] Objective: To explore the value of Paroxetine in the treatment of coronary heart disease with insomnia. Methods: 200 patients with coronary heart disease and insomnia admitted to our hospital from March 2021 to March 2023 were studied with EXCEL table. They were divided into two groups by sequential balance method. One group received psychological intervention (included in the control group), and the other group received Paroxetine treatment (included in the observation group) on the basis of the first group. Compare the clinical efficacy of 200 patients and analyze the changes in their sleep quality and psychological state after intervention. Results: The clinical efficacy of 100 patients in the observation group after Paroxetine treatment was higher than that in the control group (P<0.05); The Self Rating Scale of Sleep (SRSS) score in the observation group was lower than that in the control group (P<0.05); The Hamilton Depression Scale-17 (HAMD-17) and Hamilton Anxiety Scale (HAMA) scores in the observation group were lower than those in the control group (P<0.05). Conclusion: The choice of Paroxetine in the treatment of coronary heart disease patients with insomnia can improve their sleep quality and psychological state, and improve the overall treatment effect, which is worth learning and implementing.

Key words: Paroxetine; Coronary heart disease; Insomnia; Sleep quality; Psychological state